Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-21

Clinical Trial Update: Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass [Phase 1, Phase 2]

View source ↗

Summary

Follow-up study 5-6 years after ILIT with Birch and Grass allergens for allergic rhinitis; completed Phase 1/2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Birch and Grass ILIT

Snippet

Sponsor: Lars Olaf Cardell | Conditions: Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED